Sarah Schram

Stock Analyst at William Blair

(2.61)

# 2,182

Out of 4,761 analysts

Total ratings

100%

Success rate

13.13%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sarah Schram

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DNLI Denali Therapeutics	Initiates: Outperform	n/a	$20.73	-	1	Jan 3, 2025
	VIGL Vigil Neuroscience	Initiates: Outperform	n/a	$3.03	-	1	Dec 4, 2024

Denali Therapeutics

Jan 3, 2025

Initiates: Outperform

Price Target: n/a

Current: $20.73

Upside: -

Vigil Neuroscience

Dec 4, 2024

Initiates: Outperform

Price Target: n/a

Current: $3.03

Upside: -